AL
MDGL icon

Airain Ltd’s Madrigal Pharmaceuticals MDGL Stock Holding History

Airain Ltd’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-503
Closed -$6K – 959
2015
Q4 		$6K Buy
+503
New +$13.8K ﹤0.01% 805
2015
Q3 		– Sell
-1,458
Closed -$114K – 979
2015
Q2 		$114K Buy
+1,458
New +$122K 0.01% 808
2014
Q4 		– Sell
-1,146
Closed -$121K – 823
2014
Q3 		$121K Sell
1,146
-1,182
-51% -$164K 0.01% 727
2014
Q2 		$333K Buy
+2,328
New +$340K 0.03% 520

Other funds holding MDGL

CC
Caxton Corporation Princeton, New Jersey $1.85M AUM 176.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Airain Ltd's MDGL Position: Q1 2016 in Review

Airain Ltd sold out of Madrigal Pharmaceuticals (MDGL) in Q1 2016, closing a stake of 503 shares — an estimated $6K sold.

Airain Ltd first reported a position in MDGL in Q2 2014 and held it in 4 quarters. The position peaked at $333K in Q2 2014. 68 funds tracked by Wall St. Rank hold MDGL as of Q1 2016.

  • Airain Ltd reported no remaining Madrigal Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Airain Ltd sold 503 Madrigal Pharmaceuticals shares in Q1 2016, an estimated $6K.
  • Airain Ltd first reported a position in Madrigal Pharmaceuticals in Q2 2014 and held it in 4 quarters.
  • Airain Ltd's Madrigal Pharmaceuticals position peaked at $333K in Q2 2014.
  • 68 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q1 2016.

Based on Airain Ltd's 13F filing for Q1 2016, filed 9 May 2016.